These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 26130271)
1. Highly homologous proteins exert opposite biological activities by using different interaction interfaces. Amir AI; van Rosmalen M; Mayer G; Lebendiker M; Danieli T; Friedler A Sci Rep; 2015 Jul; 5():11629. PubMed ID: 26130271 [TBL] [Abstract][Full Text] [Related]
2. The ASPP interaction network: electrostatic differentiation between pro- and anti-apoptotic proteins. Benyamini H; Friedler A J Mol Recognit; 2011; 24(2):266-74. PubMed ID: 20623514 [TBL] [Abstract][Full Text] [Related]
3. Regulation of ASPP2 interaction with p53 core domain by an intramolecular autoinhibitory mechanism. Rotem-Bamberger S; Katz C; Friedler A PLoS One; 2013; 8(3):e58470. PubMed ID: 23472201 [TBL] [Abstract][Full Text] [Related]
4. Insight into the structural basis of pro- and antiapoptotic p53 modulation by ASPP proteins. Ahn J; Byeon IL; Byeon CH; Gronenborn AM J Biol Chem; 2009 May; 284(20):13812-13822. PubMed ID: 19246451 [TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms underlying the interaction of protein phosphatase-1c with ASPP proteins. Skene-Arnold TD; Luu HA; Uhrig RG; De Wever V; Nimick M; Maynes J; Fong A; James MN; Trinkle-Mulcahy L; Moorhead GB; Holmes CF Biochem J; 2013 Feb; 449(3):649-59. PubMed ID: 23088536 [TBL] [Abstract][Full Text] [Related]
7. A model for the interaction between NF-kappa-B and ASPP2 suggests an I-kappa-B-like binding mechanism. Benyamini H; Leonov H; Rotem S; Katz C; Arkin IT; Friedler A Proteins; 2009 Nov; 77(3):602-11. PubMed ID: 19507243 [TBL] [Abstract][Full Text] [Related]
8. Molecular basis of the interaction between the antiapoptotic Bcl-2 family proteins and the proapoptotic protein ASPP2. Katz C; Benyamini H; Rotem S; Lebendiker M; Danieli T; Iosub A; Refaely H; Dines M; Bronner V; Bravman T; Shalev DE; Rüdiger S; Friedler A Proc Natl Acad Sci U S A; 2008 Aug; 105(34):12277-82. PubMed ID: 18719108 [TBL] [Abstract][Full Text] [Related]
9. The structure and interactions of the proline-rich domain of ASPP2. Rotem S; Katz C; Benyamini H; Lebendiker M; Veprintsev D; Rüdiger S; Danieli T; Friedler A J Biol Chem; 2008 Jul; 283(27):18990-9. PubMed ID: 18448430 [TBL] [Abstract][Full Text] [Related]
10. Insights into the structure and protein-protein interactions of the pro-apoptotic protein ASPP2. Rotem S; Katz C; Friedler A Biochem Soc Trans; 2007 Nov; 35(Pt 5):966-9. PubMed ID: 17956256 [TBL] [Abstract][Full Text] [Related]
11. Factor inhibiting HIF-1 (FIH-1) modulates protein interactions of apoptosis-stimulating p53 binding protein 2 (ASPP2). Janke K; Brockmeier U; Kuhlmann K; Eisenacher M; Nolde J; Meyer HE; Mairbäurl H; Metzen E J Cell Sci; 2013 Jun; 126(Pt 12):2629-40. PubMed ID: 23606740 [TBL] [Abstract][Full Text] [Related]
12. Biochemical and structural studies of ASPP proteins reveal differential binding to p53, p63, and p73. Robinson RA; Lu X; Jones EY; Siebold C Structure; 2008 Feb; 16(2):259-68. PubMed ID: 18275817 [TBL] [Abstract][Full Text] [Related]
13. Inhibitory member of the apoptosis-stimulating proteins of the p53 family (iASPP) interacts with protein phosphatase 1 via a noncanonical binding motif. Llanos S; Royer C; Lu M; Bergamaschi D; Lee WH; Lu X J Biol Chem; 2011 Dec; 286(50):43039-44. PubMed ID: 21998301 [TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori infection and expressions of apoptosis-related proteins p53, ASPP2 and iASPP in gastric cancer and precancerous lesions. Meng WD; Chu RX; Wang BZ; Wang LP; Ma LL; Wang LX Pathol Biol (Paris); 2013 Oct; 61(5):199-202. PubMed ID: 23528480 [TBL] [Abstract][Full Text] [Related]
15. iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human. Bergamaschi D; Samuels Y; O'Neil NJ; Trigiante G; Crook T; Hsieh JK; O'Connor DJ; Zhong S; Campargue I; Tomlinson ML; Kuwabara PE; Lu X Nat Genet; 2003 Feb; 33(2):162-7. PubMed ID: 12524540 [TBL] [Abstract][Full Text] [Related]
16. [Expression of ASPP gene family and its relationship with survival of patients with non-small cell lung cancer]. Su M; Gu Y; Su S; Lu B Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):268-72. PubMed ID: 24989912 [TBL] [Abstract][Full Text] [Related]
17. Reconciling ASPP-p53 binding mode discrepancies through an ensemble binding framework that bridges crystallography and NMR data. Liu T; Huang S; Zhang Q; Xia Y; Zhang M; Sun B PLoS Comput Biol; 2024 Feb; 20(2):e1011519. PubMed ID: 38324587 [TBL] [Abstract][Full Text] [Related]
18. Abnormal expression pattern of the ASPP family of proteins in human non-small cell lung cancer and regulatory functions on apoptosis through p53 by iASPP. Li S; Shi G; Yuan H; Zhou T; Zhang Q; Zhu H; Wang X Oncol Rep; 2012 Jul; 28(1):133-40. PubMed ID: 22552744 [TBL] [Abstract][Full Text] [Related]
19. [Expressions of ASPP2, iASPP and p53 in cervical cancinoma and the significance]. Ouyang M; Hu Y; Zeng F Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 40(3):256-60. PubMed ID: 25832528 [TBL] [Abstract][Full Text] [Related]
20. An Intrinsically Disordered Region in the Proapoptotic ASPP2 Protein Binds to the Helicobacter pylori Oncoprotein CagA. Reingewertz TH; Iosub-Amir A; Bonsor DA; Mayer G; Amartely H; Friedler A; Sundberg EJ Biochemistry; 2015 Jun; 54(21):3337-47. PubMed ID: 25963096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]